Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report)'s stock price gapped up before the market opened on Monday . The stock had previously closed at $8.48, but opened at $8.84. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $8.51, with a volume of 665 shares trading hands.
Shionogi & Co., Ltd. Unsponsored ADR Trading Up 0.8%
The company has a current ratio of 6.63, a quick ratio of 6.13 and a debt-to-equity ratio of 0.01. The company has a fifty day moving average price of $8.24 and a two-hundred day moving average price of $7.63.
Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.17 by ($0.03). The company had revenue of $721.77 million for the quarter, compared to the consensus estimate of $824.23 million. As a group, equities analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current fiscal year.
About Shionogi & Co., Ltd. Unsponsored ADR
(
Get Free Report)
Shionogi & Co, Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. It offers Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment; Cabenuva and Apretude an anti-HIV and HIV prophylactic drug; Xocova an oral COVID-19 treatment drug; Finibax a carbapenem antibiotic; Xofluza, an influenza antiviral drug; and Tivicay, an anti-HIV drug.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Shionogi & Co., Ltd. Unsponsored ADR, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Shionogi & Co., Ltd. Unsponsored ADR wasn't on the list.
While Shionogi & Co., Ltd. Unsponsored ADR currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
